Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans

Delayed booster vaccination with rVSV∆G-ZEBOV-GP at 18 months promotes durable EBOV-neutralizing antibodies Longitudinal antibody repertoire ...